Funds will advance the search for new treatment options and improve patient care
SEATTLE — Sept. 26, 2014 — More than 3,000 walkers filled Seattle Center’s Next 50 Plaza on Sept. 20 for the 7th Annual Seattle Brain Cancer Walk. The walk raised more than $530,000, with 100 percent of the funds supporting research at the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment at the Swedish Neuroscience Institute (Ivy Center).
“The Seattle Brain Cancer Walk is an opportunity to celebrate the patients and families who are all affected by this devastating disease,” said Charles Cobbs, M.D., medical director of the Ivy Center. “The funds raised will make a direct impact on our research at the Ivy Center, and will help us push toward breakthroughs to better treat, and hopefully cure this disease.”
According to the American Brain Tumor Association, brain tumors are the second leading cause of cancer-related deaths in Americans under the age of 20; the second leading cause of cancer-related deaths in men ages 20-39; and the fifth leading cause of cancer-related deaths in women ages 20-39.
Prior to the opening of the Ivy Center in 2008, clinical trials for patients with brain tumors were extremely limited in the Pacific Northwest. To date, the Ivy Center has provided access to 15 community-based clinical trials of experimental new therapies for patients diagnosed with brain cancer.